CVD Risk Estimator Plus vs Pharmix فارمیکس
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
CVD Risk Estimator Plus
This clinical decision support app provides comprehensive cardiovascular disease risk assessments for clinicians. It unifies two major risk calculators, incorporating traditional ASCVD modeling with modern kidney and metabolic health measures for personalized patient care.
- Combines ASCVD and PREVENT calculators
- Calculates 10-year and lifetime CVD risk
- Incorporates kidney and metabolic health
- Provides risk category classification
- Exports results for documentation
- Includes clinician and patient resources
Read full descriptionHide full description
This clinical decision-support app is intended for use by healthcare professionals and unifies two cardiovascular prevention tools: the 2013 ACC/AHA Pooled Cohort Equations (previously known as the ASCVD Risk Estimator) and the American Heart Association’s PREVENT™ Calculator. Combining traditional ASCVD risk modeling with modern cardiovascular-kidney-metabolic (CKM)-inclusive risk equations, CVD Risk Estimator Plus supports comprehensive, personalized cardiovascular disease (CVD) risk assessment and clinician-guided decision-making. The results and recommendations provided by this application are intended to inform but do not replace clinical judgment. Therapeutic options should be individualized and determined after discussion between the patient and their care provider. CVD Risk Estimator Plus computes risk estimates using: • 2013 ASCVD Pooled Cohort Equations (PCE), which calculate 10-year and lifetime risk of atherosclerotic cardiovascular disease using age, sex, race, blood pressure, cholesterol profile, diabetes status, and smoking status. • 2023 PREVENT™ Equations, which estimate 10- and 30-year risk for total CVD, ASCVD, and heart failure (HF), incorporating kidney and metabolic health measures such as BMI and estimated glomerular filtration rate (eGFR), and supporting optional predictors including urine albumin creatinine ratio (UACR), hemoglobin A1c (HbA1c), and social deprivation index (SDI). Clinicians can toggle between Pooled Cohort and PREVENT™ risk trajectories to support guideline-aligned prevention discussions. This clinical decision support app provides: • Risk category classification (low, borderline, intermediate, high). • Personalized guidance informed by published guidelines, including statin therapy considerations, lifestyle interventions, and risk-enhancing clinical factors. • Export functionality supporting print and email of results for documentation and patient communication. • Resources page with related tools and informational materials for clinicians and patients, including links to source guidelines and reference documents.
Pharmix فارمیکس
This app allows users to browse and order medications from pharmacies. It simplifies the process of finding available products and completing purchases.
- Browse available pharmacy products
- Add items to cart
- Place medication orders
- User-friendly interface
Read full descriptionHide full description
Pharmix is a mobile app for pharmacies and ordering medications. Browse available products, add items to your cart, and place your order with ease.
Screenshots
Verdict
CVD Risk Estimator Plus and Pharmix فارمیکس both sit at 5.0 stars, but that hides the real split: 100% of Pharmix فارمیکس's written reviews are positive against 32% of CVD Risk Estimator Plus's. Pharmix فارمیکس also leads on update cadence (every 2 weeks vs every 4 months) and ratings volume (10 vs 1). On price, rating, ads and in-app purchases there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
On the App Store both sit at effectively the same score — 5.0 for CVD Risk Estimator Plus against 4.9 for Pharmix فارمیکس. That said, the two scores are not equally well evidenced: Pharmix فارمیکس has 10 ratings behind it against 1, so its average is the more settled of the two. Written reviews are what separate them: 32% of CVD Risk Estimator Plus's written reviews are positive against 100% of Pharmix فارمیکس's.
CVD Risk Estimator Plus ships an update every 4 months, Pharmix فارمیکس every 2 weeks. The most recent releases landed on October 17, 2026 and October 6, 2026 respectively.
| Parameter | CVD Risk Estimator Plus | Pharmix فارمیکس |
|---|---|---|
| Price | Free | Free |
| Rating | 5.0 (1 ratings) — better | 4.9 (10 ratings) |
| Positive reviews | 31.6% of reviews | 100.0% of reviews — better |
| Number of ratings | 1 | 10 — better |
| Update frequency | Every 4 months | Every 2 weeks — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | Free |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 13.0 | 13.0 |
| Further details — not scored | ||
| Size | 59 MB | 51 MB |
| Age rating | 17+ | 4+ |
| Developer | American College of Cardiology | WeserMedic |
Customer experience
CVD Risk Estimator Plus
Pharmix فارمیکس
In-app purchases
CVD Risk Estimator Plus
No in-app purchases
Pharmix فارمیکس
No in-app purchases
Questions
Is CVD Risk Estimator Plus free?
Is Pharmix فارمیکس free?
Which has better reviews, CVD Risk Estimator Plus or Pharmix فارمیکس?
Do CVD Risk Estimator Plus or Pharmix فارمیکس have ads?
Which is updated more often, CVD Risk Estimator Plus or Pharmix فارمیکس?
Other comparisons
